Training Program in Cancer Therapeutics
癌症治疗培训计划
基本信息
- 批准号:9103733
- 负责人:
- 金额:$ 4.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-01 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): To improve cancer therapy, it is increasingly critical that advances in basic cancer research be translated to the clinic. In the Training Program in Cancer Therapeutics, the goal is to provide training to cancer researchers in the action of therapeutic agents used in the treatment of cancer. This Training Program will be multi-disciplinary and expose the trainees to both basic research involving cancer therapeutic agents and the clinical utilization of therapeutics. A particular emphasis will be placed on the mechanisms through which basic scientific discovery is brought into the clinic through clinical trials. To facilitate this training, a team of mentoring faculty and ancillary clinical faculty hasbeen recruited into the Training Program from the University of Cincinnati and Cincinnati Children's Hospital Medical Center. Mentors on this training program are independently funded, have experience in mentoring, and work on projects related to cancer therapy. The ancillary faculty are clinical partners on this proposal, who will educate on the clinical utilization of specific therapeutic modalities. Together, the mentors and ancillary faculty will provide training both through direct interactions and through specialized educational activities and course work for the Training Program. This Program will provide outstanding career development for trainees, as more emphasis is placed on translating basic scientific discovery into improved patient care. Logistically, the Training Program in Cancer Therapeutics has 17 mentors and 6 ancillary faculty. It is administered by the Principal Investigators and Administrative Committees, which are directed at training excellence and providing an ethnically and scientifically diverse group of
trainees. The Training Program requests support for 6 postdoctoral and 2 predoctoral trainees. The program will be evaluated regularly through both internal and external review to ensure that the trainees are receiving the best possible training.
描述(由申请人提供):为了改善癌症治疗,将基础癌症研究的进展转化为临床变得越来越重要。在癌症治疗学培训项目中,目标是为癌症研究人员提供治疗药物在癌症治疗中的作用方面的培训。这个培训项目将是多学科的,使受训者接触到涉及癌症治疗药物的基础研究和治疗药物的临床应用。将特别强调通过临床试验将基础科学发现带入临床的机制。为了促进培训,从辛辛那提大学和辛辛那提儿童医院医学中心招募了一个由指导教师和辅助临床教师组成的团队参加培训项目。这个培训项目的导师是独立资助的,有指导经验,从事与癌症治疗相关的项目。辅助教师是该建议的临床合作伙伴,他们将对特定治疗方式的临床应用进行教育。导师和辅助教师将共同通过直接互动和专门的教育活动以及培训计划的课程作业提供培训。该项目将为学员提供出色的职业发展机会,更注重将基础科学发现转化为更好的患者护理。从后勤上讲,癌症治疗培训项目有17名导师和6名辅助教师。它由主要调查人员和行政委员会管理,旨在培训优秀人才,并提供一个种族和科学多样化的小组
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carolyn M Price其他文献
Carolyn M Price的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carolyn M Price', 18)}}的其他基金
Function and Dynamics of Tetrahymena Telomere Proteins
四膜虫端粒蛋白的功能和动态
- 批准号:
7903093 - 财政年份:2009
- 资助金额:
$ 4.62万 - 项目类别:
Function and Dynamics of Tetrahymena Telomere Proteins
四膜虫端粒蛋白的功能和动态
- 批准号:
8300897 - 财政年份:2009
- 资助金额:
$ 4.62万 - 项目类别:
Function and Dynamics of Tetrahymena Telomere Proteins
四膜虫端粒蛋白的功能和动态
- 批准号:
8094506 - 财政年份:2009
- 资助金额:
$ 4.62万 - 项目类别:
Conference Proposal to support FASEB Conference on Ciliate Molecular Biology
支持 FASEB 纤毛虫分子生物学会议的会议提案
- 批准号:
7327387 - 财政年份:2007
- 资助金额:
$ 4.62万 - 项目类别:
相似海外基金
Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
- 批准号:
24K10442 - 财政年份:2024
- 资助金额:
$ 4.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Intelligent Breast Cancer DiagnOsis and MonItoring Therapeutic Response Training Network (CanDoIt)
智能乳腺癌诊断和监测治疗反应训练网络(CanDoIt)
- 批准号:
EP/Y03693X/1 - 财政年份:2024
- 资助金额:
$ 4.62万 - 项目类别:
Research Grant
Non invasive methods to accelerate the development of injectable therapeutic depots
非侵入性方法加速注射治疗储库的开发
- 批准号:
EP/Z532976/1 - 财政年份:2024
- 资助金额:
$ 4.62万 - 项目类别:
Research Grant
GPR35: mechanisms of action and agonism as a potential therapeutic strategy for non-alcoholic fatty liver diseases
GPR35:作为非酒精性脂肪肝疾病潜在治疗策略的作用和激动机制
- 批准号:
MR/X008827/1 - 财政年份:2024
- 资助金额:
$ 4.62万 - 项目类别:
Research Grant
Collaborative Research: CPS: Medium: Automating Complex Therapeutic Loops with Conflicts in Medical Cyber-Physical Systems
合作研究:CPS:中:自动化医疗网络物理系统中存在冲突的复杂治疗循环
- 批准号:
2322534 - 财政年份:2024
- 资助金额:
$ 4.62万 - 项目类别:
Standard Grant
Uncovering the antimicrobial and antibiotic potentiating mechanism of acesulfame-K and maximising its topical therapeutic potential.
揭示安赛蜜的抗菌和抗生素增强机制并最大限度地发挥其局部治疗潜力。
- 批准号:
MR/Y001354/1 - 财政年份:2024
- 资助金额:
$ 4.62万 - 项目类别:
Research Grant
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 4.62万 - 项目类别:
Collaborative R&D
Preclinical validation of synthetic biomolecules to treat Breast Cancer from AI-enabled discovery of novel lncRNA therapeutic targets.
通过人工智能发现新型 lncRNA 治疗靶点,对合成生物分子治疗乳腺癌进行临床前验证。
- 批准号:
10110204 - 财政年份:2024
- 资助金额:
$ 4.62万 - 项目类别:
Launchpad
Analysis and quality control of novel mixed cell population for therapeutic development
用于治疗开发的新型混合细胞群的分析和质量控制
- 批准号:
10089851 - 财政年份:2024
- 资助金额:
$ 4.62万 - 项目类别:
Collaborative R&D
Using patient-led genetics to identify new therapeutic targets in metastatic cholangiocarcinoma
利用患者主导的遗传学来确定转移性胆管癌的新治疗靶点
- 批准号:
EP/Y028546/1 - 财政年份:2024
- 资助金额:
$ 4.62万 - 项目类别:
Fellowship